Organon (OGN) EBT Margin (2020 - 2026)

Organon (OGN) recorded quarterly EBT Margin of 14.59% in Q1 2026, up 248.55% quarter-over-quarter from 9.82% in Q4 2025, and up 791.0% on a YoY basis from 1.64% in Q1 2025.

Organon (OGN) EBT Margin (2020 - 2026) Analysis & Trends

Organon's EBT Margin history runs 7 years deep, the most recent figure standing at 14.59% for Q1 2026.

  • In Q1 2026, EBT Margin rose 791.0% year-over-year to 14.59%; the TTM figure through Mar 2026 stood at 8.71% (down 196.0% YoY), while the FY2025 annual figure was 6.84%, down 577.0% from the prior year.
  • EBT Margin was 14.59% for Q1 2026 at Organon, up from 9.82% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 37.85% in Q4 2022 to a low of 9.82% in Q4 2025.
  • Historically, EBT Margin has averaged 13.92% across 5 years, with a median of 14.59% in 2026.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 2312 bps in 2022, then tumbled 3134 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 37.85% in 2022, then tumbled by 83 bps to 6.51% in 2023, then grew by 25 bps to 8.1% in 2024, then plunged by 221 bps to 9.82% in 2025, then jumped by 249 bps to 14.59% in 2026.
  • The last three EBT Margin figures came in at 14.59% (Q1 2026), 9.82% (Q4 2025), and 15.17% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 28.10%
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 44.70%
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 24.89%
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 6.93%
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -21.49%
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 24.18%
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 37.07%
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 135.53%
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 28.20%
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 14.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.59%
Dec 31, 2025 -9.82%
Sep 30, 2025 15.17%
Jun 30, 2025 14.37%
Mar 31, 2025 6.68%
Dec 31, 2024 8.10%
Sep 30, 2024 13.08%
Jun 30, 2024 14.62%
Mar 31, 2024 14.55%
Dec 31, 2023 6.51%
Sep 30, 2023 5.27%
Jun 30, 2023 15.80%
Mar 31, 2023 15.28%
Dec 31, 2022 37.85%
Sep 30, 2022 18.35%
Jun 30, 2022 18.11%
Mar 31, 2022 28.21%
Dec 31, 2021 14.72%
Sep 30, 2021 24.31%
Jun 30, 2021 27.40%